Maud Janvier
- Hematology top 1%
- Oncology top 5%
- Molecular Biology
- Genetics top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Véronique LeblondRoland BergerMarine DivinéM BoironG TobelemYves CharpakSylvia BellucciGeorges Flandrin
- Topics
- Lymphoma Diagnosis and Treatment (12 papers)Cancer Treatment and Pharmacology (10 papers)Breast Cancer Treatment Studies (10 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- FranceBelgiumLuxembourg
In The Last Decade
Maud Janvier
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 77
- Hematology 918
- Oncology 597
- Molecular Biology 500
- Genetics 483
- Pathology and Forensic Medicine 382
Countries citing papers authored by Maud Janvier
This map shows the geographic impact of Maud Janvier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Janvier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Janvier more than expected).
Fields of papers citing papers by Maud Janvier
This network shows the impact of papers produced by Maud Janvier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Janvier. The network helps show where Maud Janvier may publish in the future.
Co-authorship network of co-authors of Maud Janvier
This figure shows the co-authorship network connecting the top 25 collaborators of Maud Janvier. A scholar is included among the top collaborators of Maud Janvier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud Janvier. Maud Janvier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 54 | |
| 3 | 8 | |
| 4 | 89 | |
| 5 | 24 | |
| 6 | 40 | |
| 7 | 1 | |
| 8 | 35 | |
| 9 | 25 | |
| 10 | 57 | |
| 11 | 44 | |
| 12 | 22 | |
| 13 | 31 | |
| 14 | Association mitomycine-vinorelbine en deuxième ligne chimiothérapique dans le cancer du sein métastatique | 3 |
| 15 | 38 | |
| 16 | Late delayed adjuvant tamoxifen in early breast cancer. Results of a cooperative randomized trial | 1 |
| 17 | Tamoxifène adjuvant retardé dans le cancer du sein curable. Résultats d’un essai coopératif randomisé | 3 |
| 18 | 79 | |
| 19 | 8 | |
| 20 | 3 |
About Maud Janvier
Maud Janvier is a scholar working on Hematology, Oncology and Genetics, having authored 48 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Cancer Treatment and Pharmacology (10 papers) and Breast Cancer Treatment Studies (10 papers). The work is most often cited by research in Hematology (918 citations), Genetics (483 citations) and Oncology (597 citations). Maud Janvier has collaborated with scholars based in France, Belgium and Luxembourg. Frequent co-authors include Véronique Leblond, Roland Berger, Marine Diviné, M Boiron, G Tobelem, Yves Charpak, Sylvia Bellucci, Georges Flandrin, Bruno Royer and Margaret Macro. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.